Профилактическая медицина и здоровье 2-том 2-нөмір (2023) · 31-38-беттер
Ways to optimize treatment and prevention programs for HIV-associated urinary tract infections
Mamasoliev, Z, Mamasoliev, N, Kalandarov, M, Usmonov, B, Мамасолиев, З, Мамасолиев, Н, Каландаров, M, Усмонов, Б, Mamasoliev, Z, Mamasoliev, N, Qalandarov, M, Usmonov, B
Аңдатпа
The high incidence of clinical symptoms of BMI in women and men with ART compared to the group of women and men with BMI without APBT appears to be explained by the fact that antiretroviral therapy can slow the progression of HIV infection, but stop the development of BMI and achieve cure for the patient with BMI she is not able to. Gradual suppression of immunity from the stage of HIV infection to AIDS-associated BMI contributes to an increased risk of infectious and inflammatory complications in the form of BMI and a pronounced tendency for its severe clinical manifestations.
ВИЧ-ассоциированные инфекциифармакоэпидемиологияпрофилактикафакторы рискаHIV-associated infectionspharmacoepidemiologypreventionisk factorsOIV bilan bog'liq infektsiyalarfarmakoepidemiologiya
Метадеректер дереккөзі: журналдың OAI-PMH архиві · Sindex толық мәтінді сақтамайды, дереккөзге сілтеме береді.